This year could be defined by a return to normality and recovery. In fact, our country is set to receive EU funds with the clear objective of reversing the damage caused by the pandemic over the past two years.
Results for: Markets research
Is now a good time to buy equities?
Many experts say last year was positive for the vast majority of indexes but somewhat tricky for active management.
Market unknowns for this year
2021 is now history. After one of the best years in stock market history, investors fear that the markets may have peaked.
Caution with the Christmas rally: “Any minor change can become magnified”
Markets are already gearing up for next year with signs of hope, but also caution: investors are aware that the epidemiological situation may cast a shadow of uncertainty on the first months of 2022.
Omicron: a threat to world growth?
Even if we have yet to suffer the most severe effects of this new wave of infections, analysts are already recalibrating growth expectations that will be affected, at least in the short term.
What can we expect from central banks in 2022?
Main central banks ended the year with key meetings in which they announced a new direction for monetary policy.
The IBEX: a golden opportunity in 2022
The year 2021 will end the uncertainty in the markets about the Omicron variant and its possible effects on next year's forecasts.
“The markets can absorb the interest-rate hikes in the U.S., which are being discounted”
The U.S. bond market is already discounting three interest-rate hikes in 2022.
Buybacks: yes, but not at any price
According to analysts’ estimates, the amount allocated for this purpose will once again exceed 100 billion euros this year for the aggregate of the current STOXX Europe 600 Index components.